0001209191-22-059573.txt : 20221205 0001209191-22-059573.hdr.sgml : 20221205 20221205122850 ACCESSION NUMBER: 0001209191-22-059573 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221201 FILED AS OF DATE: 20221205 DATE AS OF CHANGE: 20221205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lecault Veronique CENTRAL INDEX KEY: 0001834418 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 221444249 MAIL ADDRESS: STREET 1: C/O ABCELLERA BIOLOGICS INC. STREET 2: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbCellera Biologics Inc. CENTRAL INDEX KEY: 0001703057 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 BUSINESS PHONE: (604) 559-9005 MAIL ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-01 0 0001703057 AbCellera Biologics Inc. ABCL 0001834418 Lecault Veronique C/O ABCELLERA BIOLOGICS INC. 2215 YUKON STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA 1 1 0 0 Chief Operating Officer Share Options (right to buy) 13.18 2022-12-01 4 A 0 462535 0.00 A 2032-12-01 Common Shares 462535 3392689 D The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date. /s/ Tryn Stimart, attorney-in-fact 2022-12-05